Company Zoetis Inc.

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 01:30:02 25/05/2024 am IST 5-day change 1st Jan Change
170.1 USD -0.49% Intraday chart for Zoetis Inc. -2.29% -13.83%

Business Summary

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:

- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);

- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);

- other (1.1%).

Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).

At the end of 2022, the group has 29 production sites worldwide.

The United States accounts for 53.4% of net sales.

Number of employees: 14,100

Sales per Business

USD in Million2022Weight2023Weight Delta
Parasiticides
22.8 %
1,860 23.0 % 1,947 22.8 % +4.68%
Vaccines
20.7 %
1,718 21.3 % 1,771 20.7 % +3.08%
Dermatology
16.7 %
1,329 16.4 % 1,427 16.7 % +7.37%
Other Pharmaceuticals
15.0 %
1,043 12.9 % 1,280 15.0 % +22.72%
Anti-infectives
12.4 %
1,081 13.4 % 1,057 12.4 % -2.22%
Animal Health Diagnostics
4.4 %
353 4.4 % 376 4.4 % +6.52%
Medicated Feed Additives
4.1 %
360 4.5 % 354 4.1 % -1.67%
Other Non-pharmaceuticals
3.0 %
250 3.1 % 254 3.0 % +1.60%
Contract Manufacturing and Human Health
0.9 %
86 1.1 % 78 0.9 % -9.30%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
53.3 %
4,313 53.4 % 4,555 53.3 % +5.61%
Other Emerging Markets
9.2 %
758 9.4 % 784 9.2 % +3.43%
Other Developed Markets
6.0 %
468 5.8 % 512 6.0 % +9.40%
Brazil
4.6 %
330 4.1 % 393 4.6 % +19.09%
Australia
3.8 %
289 3.6 % 323 3.8 % +11.76%
China
3.7 %
382 4.7 % 320 3.7 % -16.23%
United Kingdom
3.2 %
235 2.9 % 277 3.2 % +17.87%
Canada
3.0 %
238 2.9 % 255 3.0 % +7.14%
Germany
2.4 %
176 2.2 % 202 2.4 % +14.77%
Mexico
1.9 %
136 1.7 % 162 1.9 % +19.12%
Japan
1.8 %
173 2.1 % 158 1.8 % -8.67%
France
1.7 %
126 1.6 % 142 1.7 % +12.70%
Chile
1.6 %
141 1.7 % 140 1.6 % -0.71%
Spain
1.4 %
118 1.5 % 122 1.4 % +3.39%
Italy
1.4 %
111 1.4 % 121 1.4 % +9.01%
Global
0.9 %
86 1.1 % 78 0.9 % -9.30%

Managers

Managers TitleAgeSince
Chief Executive Officer 52 01/12/01
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 01/11/01
Chief Tech/Sci/R&D Officer 56 01/15/01
Chief Tech/Sci/R&D Officer 56 01/20/01
Investor Relations Contact - 01/15/01
Corporate Officer/Principal - -
Corporate Officer/Principal - 10/23/10
Corporate Officer/Principal - -
Human Resources Officer 59 01/12/01

Members of the board

Members of the board TitleAgeSince
Chairman 71 01/13/01
Director/Board Member 73 01/13/01
Director/Board Member 74 01/13/01
Chief Executive Officer 52 01/12/01
Director/Board Member 63 01/15/01
Director/Board Member 66 01/12/01
Director/Board Member 71 01/13/01
Director/Board Member 66 01/13/01
Director/Board Member 55 25/22/25
Director/Board Member 69 04/14/04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 501,239,175 455,188,500 ( 90.81 %) 44,944,038 ( 8.967 %) 90.81 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
8.910 %
40,749,571 8.910 % 6 249 M $
BlackRock Advisors LLC
5.933 %
27,136,623 5.933 % 4 162 M $
19,570,006 4.279 % 3 001 M $
State Farm Investment Management Corp.
3.531 %
16,151,379 3.531 % 2 477 M $
Merrill Lynch International
3.094 %
14,150,985 3.094 % 2 170 M $
AllianceBernstein LP
2.970 %
13,585,758 2.970 % 2 084 M $
Eaton Vance Management
2.816 %
12,878,401 2.816 % 1 975 M $
Geode Capital Management LLC
2.197 %
10,048,001 2.197 % 1 541 M $
T. Rowe Price International Ltd.
2.049 %
9,372,104 2.049 % 1 437 M $
Wellington Management Co. LLP
2.023 %
9,254,609 2.023 % 1 419 M $

Company contact information

Zoetis, Inc.

10 Sylvan Way

07054, Parsippany

+973 822 7000

http://www.zoetis.com
address Zoetis Inc.(ZTS)

Group companies

NameCategory and Sector
Zoetis Treasury Center BV
Biotechnology
Pharmaceuticals: Major
Zoetis Philippines, Inc.
Pharmaq Vietnam Co. Ltd.
Zoetis Pharmaceutical Research Pvt Ltd.
Pharmaceuticals: Major
Zoetis Singapore Pte Ltd.
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
170.1 USD
Average target price
211.2 USD
Spread / Average Target
+24.19%
Consensus